English
Regional settings| Spread | 0.30 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ HK$5,000.00 Short position overnight fee ~ HK$4,000.00 | -0.022639% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ HK$5,000.00 Short position overnight fee ~ HK$4,000.00 | 0.000721% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | HKD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Hong Kong | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 13.85 |
| Open | 13.55 |
| 1-Year Change | -70.77% |
| Day's Range | 13.55 - 13.85 |
WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing of biologics services. The Company's technology platforms include WuXiBody TM bispecific antibody technology platform and antibody drug conjugates (ADC) technology platform. It has brought in several new projects into its pipeline. The Company has a vaccine manufacturing facility and produces vaccines for customers to supply the global market. The Company conducts its businesses within the China market and to overseas markets, such as North America, Europe and other markets.
BRIEF: For the fiscal year ended 31 December 2021, WuXi Biologics (Cayman) Inc revenues increased 83% to RMB10.29B. Net income increased from RMB1.69B to RMB3.39B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from FV gain - unlisted investments at FVTPL increase from RMB3M to RMB74.4M (income).
